F/M Emerald Life Sciences Innovation ETF (LFSC) closed at $42.58 on October 22, 2026, down 0.1% from the previous close, on volume of 20,555 shares (30-day average 2,756).
Data as of October 22, 2026.
No headlines found.
No press releases found.
No news found.
F/m Emerald Life Sciences Innovation ETF is an actively managed ETF that invests primarily in equity securities of life sciences companies. The fund selects investments based on breakthrough science and innovation, targeting unique growth opportunities across companies of any size. The Fund's investments include common and preferred stock, other investment companies, and depositary receipts. It may also invest in private placements, warrants, rights, and initial public offerings.
F/M Emerald Life Sciences Innovation ETF trades on the NASDAQ stock market under the symbol LFSC.
As of October 22, 2026, LFSC stock price declined to $42.58 with 20,555 million shares trading.
LFSC has a market cap of $118.25 million. This is considered a Micro Cap stock.
LFSC has outperformed the market in the last year with a price return of +38.3% while the SPY ETF gained +15.5%. However, in the short term, LFSC had mixed performance relative to the market. It has underperformed in the last 3 months, returning -5.4% vs +2.5% return in SPY. But in the last 2 weeks, LFSC shares have fared better than the market returning +2.2% compared to SPY -1.3%.
LFSC support price is $41.75 and resistance is $43.47 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LFSC shares will trade within this expected range on the day.
